ÂÜÀòÂÒÂ×

Peter has over 24 years of experience in the biopharma industry, most recently as Chief Financial Officer and Chief Business Officer of Pharnext SA, a public late-stage biotech company focused on combination drug approaches in orphan neurology. Previously, he spent 17 years in healthcare investment banking at both Bank of America and MTS Health Partners, focused on M&A, financing and business development transactions for both public and private life sciences companies in the US and abroad. He started his career in the pharma industry as an engineer at Roche. Peter holds an MBA from the University of Chicago Booth School of Business and a BS from the Rutgers University College of Engineering.